文献速递创伤与烧伤呼吸衰竭与机械通气

胸廓损伤后再入院率及相关因素

Readmission rates and associated factors following rib cage injury.
PubMed 文献 · J Trauma Acute Care Surg · 2019-01-01
一句话结论中重度胸廓损伤患者90天内23.1%再次急诊评估、10.3%再入院,年轻吸烟及曾非计划重返ICU者风险更高。

本研究为城市一级创伤中心2014年1月至2016年12月的回顾性综述,纳入钝性创伤后超过一根肋骨骨折或胸骨柄骨折的成人中重度胸廓损伤患者,排除穿透伤、初次住院期间死亡及仅单根肋骨骨折者。共1717例中重度胸廓损伤患者,90天内397例(23.1%)再次急诊评估,177例(10.3%)再入院;其中因胸部相关主诉再次评估142例(8.3%),再入院55例(3.2%)。多因素分析显示15至35岁、风险评估档案评分大于8、高血压、精神疾病共病、当前吸烟及初次住院期间非计划重返ICU是总体再次评估的预测因素。作者结论认为中重度胸廓损伤与高再评估率和再入院率相关,年轻吸烟及需重返ICU的患者再入院风险更高。

要点

  • 中重度胸廓损伤(超过一根肋骨骨折或胸骨柄骨折)患者90天内再入院率10.3%(177/1717),总体再次急诊评估率23.1%(397/1717)。
  • 因胸部相关主诉再次急诊评估者占8.3%(142/1717),因胸部相关主诉再入院者占3.2%(55/1717)。
  • 多因素分析中15至35岁、风险评估档案评分大于8、高血压、精神疾病共病、当前吸烟及初次住院非计划重返ICU预测总体再次评估。
  • 单因素分析中损伤严重度评分大于15、住院超过7天、ICU停留超过3天、出院时胸片恶化、精神疾病共病、吸烟共病、深静脉血栓、非计划重返ICU及非计划插管在总体再次评估队列中更高。
  • 作者结论认为年轻、吸烟及初次住院需重返ICU的患者再入院风险更高。

适用人群与场景

  • 城市一级创伤中心2014年1月至2016年12月评估的成人钝性创伤患者,定义为中重度胸廓损伤:超过一根肋骨骨折或胸骨柄骨折。
  • 排除穿透伤、初次住院期间死亡及仅一根肋骨骨折的患者。

诊断标准与关键阈值

  • 中重度胸廓损伤定义:钝性创伤后超过一根肋骨骨折或胸骨柄骨折。
  • 再次评估定义:出院后90天内紧急或急诊就诊于医院。

研究设计与关键结果

  • 回顾性综述,研究期间11667例创伤评估患者中1717例为中重度胸廓损伤。
  • 90天内397例(23.1%)再次急诊评估,177例(10.3%)再入院;因胸部相关主诉再次评估142例(8.3%),再入院55例(3.2%)。
  • 单因素分析中损伤严重度评分大于15、住院超过7天、ICU停留超过3天、出院时胸片恶化、精神疾病共病、吸烟共病、深静脉血栓、非计划重返ICU及非计划插管在总体再次评估队列中更高。
  • 多因素分析中15至35岁、风险评估档案评分大于8、高血压、精神疾病共病、当前吸烟及初次住院非计划重返ICU预测总体再次评估。

证据类型、等级与局限

  • 证据类型:回顾性综述;证据等级:Level IV,预后与流行病学。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为中重度胸廓损伤与高再评估率和再入院率相关。
  • 作者认为年轻、吸烟及初次住院期间需要重返ICU的患者再入院风险更高。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: There remains a lack of knowledge about readmission characteristics after sustaining rib fractures. We aimed to determine rates, characteristics, and predictive/protective factors associated with unexpected reevaluation and readmission after rib cage injury.

METHODS: A retrospective review was performed based on trauma patients evaluated at an urban Level I trauma center from January 2014 to December 2016. Adult patients sustaining blunt trauma with more than one rib fracture or a sternomanubrial fracture were defined as having moderate to severe rib cage injury. Exclusion criteria included penetrating injury, death during initial hospitalization, and only one rib fracture. Reevaluation was defined as presenting at a hospital within 90 days of discharge urgently or emergently. Demographics, injury characteristics, comorbidities, complications, imaging, and readmission data were collected. Univariate and multivariate analysis was performed with a significance of p less than 0.05.

RESULTS: During the study period, 11,667 patients underwent trauma evaluation, of which 1,717 patients were found to have a moderate to severe rib cage injury. Within 90 days, 397 (23.1%) of patients underwent reevaluation, while 177 (10.3%) required readmission. One hundred forty-two (8.3%) patients were reevaluated specifically for chest-related complaints, and 55 (3.2%) required readmission. On univariate analysis, Injury Severity Score greater than 15, hospital length of stay longer than 7 days, intensive care unit (ICU) length of stay longer than 3 days, a worsened chest x-ray at discharge, a psychiatric comorbidity, a smoking comorbidity, deep vein thrombosis, unplanned readmission to the ICU, and unplanned intubation were higher in the overall reevaluation cohort. On multivariate analysis, age of 15 years to 35 years, Risk Assessment Profile score greater than 8, hypertension, psychiatric comorbidity, current smoker, and unplanned return to the ICU on index admission were predictive of reevaluation of overall reevaluation.

CONCLUSION: Moderate to severe rib cage injury is associated with high rates of reevaluation and readmission. Younger patients who smoke and required a return to the ICU are at greater risk for readmission.

LEVEL OF EVIDENCE: Level IV, Prognostic and Epidemiologic.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Baker JE, Skinner M, Heh V, et al. Readmission rates and associated factors following rib cage injury. J Trauma Acute Care Surg. 2019. PMID: 31205215. doi:10.1097/TA.0000000000002390

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。